| Value | ₹19,000 Cr |
|---|---|
| Execution period | FY 2026-27 |
BSE filing, NSE: SBIN. Summary written from the filing by ALFA Finder's alert engine.
State Bank of India: key numbers
- Share price
- ₹961.85
- Market cap
- ₹8,87,847 Cr
- Revenue (annual)
- ₹5,14,933 Cr
- Net profit (annual)
- ₹83,299 Cr
- P/E (TTM)
- 10.3×Sector 19.8×
- Promoter holding
- 55.45%-0.02% QoQ
- FII holding
- 11.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from State Bank of India
All →State Bank of India Debt & Borrowing: ₹399 Cr
State Bank of India paid ₹399 Crore annual interest on its AT1 bond series INE062A08462. Payment was made on October 26, 2026 after holiday shifts.
- Value
- ₹399.0 Cr
State Bank of India Board Meeting Date
State Bank of India announced a Prior Intimation of its board meeting on 3rd November 2026 to consider Q2FY27 results. An analyst meet and trading window closure are also scheduled.
State Bank of India Debt & Borrowing: ₹519.8 Cr
State Bank of India paid annual interest of ₹51.98 Crore on its Basel III compliant Tier 2 bond series (ISIN: INE062A08488).
- Value
- ₹519.8 Cr
State Bank of India Adverse Business Impact
SBI reported a data breach involving 3,897 customer records exposed on the dark web. The bank confirmed no material impact on core business or financial performance.
State Bank of India Debt & Borrowing: ₹463.2 Cr
State Bank of India successfully paid Rs. 463.20 Crore as interest on its 7.72% Basel III AT1 Bonds, confirming the timely fulfillment of its payment obligation.
- Value
- ₹463.2 Cr
State Bank of India Debt & Borrowing: ₹6,000 Cr
State Bank of India has completed the full redemption of its 7.72% Basel III AT1 bonds, amounting to ₹6,000 Crore.
- Value
- ₹6,000 Cr
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.